In this paper we consider Abelian vector plus scalar holographic gravity models for 2+1 dimensional condensed matter transport, and the effect of S-duality on them. We find the transport coefficients from the electric and heat currents via usual membrane paradigm-type calculations, and the effect of S-duality on them. We study the same system also by using the entropy function formalism in the extremal case, and the formalism of holographic Stokes equations, in the case of one-dimensional lattices. We study a few generalizations that appear when considering a supergravity-inspired model, and apply the entropy function method for them. *
In this paper we study particle-vortex duality and the effect of theta terms from the point of view of AdS/CMT constructions. We can construct the duality in 2+1 dimensional field theories with or without a Chern-Simons term, and derive an effect on conductivities, when the action is viewed as a response action. We can find its effect on 3+1 dimensional theories, with or without a theta term, coupled to gravity in asymptotically AdS space, and derive the resulting effect on conductivities defined in the spirit of AdS/CFT. AdS/CFT then relates the 2+1 dimensional and the 3+1 dimensional cases naturally. Quantum gravity corrections, as well as more general effective actions for the abelian vector, can be treated similarly. We can use the fluid/gravity correspondence, and the membrane paradigm, to define shear and bulk viscosities η and ζ for a gravity plus abelian vector plus scalar system near a black hole, and define the effect of the S-duality on it. * 1 See e.g., [21,22] for an early example of 2+1 dimensional duality in the path integral.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.